Intranasal Dexmedetomidine on Stress Hormones, Inflammatory Markers, and Postoperative Analgesia after Functional Endoscopic Sinus Surgery

Figure 4

Median postoperative VAS pain scores of patients receiving intranasal DEX and placebo at each recording time point. The areas under curves (AUC) of VAS pain scores for 2–12 h were significantly lower in DEX group than Placebo group (). Values are given as Median (IQR (range)). , .